phase readout
saveNCT03899259: A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
COMPLETEDupdated 1h ago
community read0 votes
Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Alopecia Areata
view source ↗
comments(0)
5-min edit window · permanent after that